查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1706773

門診輸液中心市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Ambulatory Infusion Centers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

門診輸液中心市場-報告範圍

TMR 關於全球門診輸液中心市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球門診輸液中心市場的收入，以 2025 年為基準年，2035 年為預測。該報告也提供了 2025 年至 2035 年全球門診輸液中心市場的年複合成長率(CAGR %)。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解門診輸液中心市場。

市場概況
2024 年的市場價值 203億美元
2035年的市場價值 523億美元
複合年成長率 8.9%

該報告深入探討了全球門診輸液中心市場的競爭格局。我們已經確定了在全球門診輸液中心市場中營運的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球門診輸液中心市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球市場分析與預測

第5章：關鍵見解

  • 重要行業活動
  • PESTEL分析
  • 主要國家/地區監管情況
  • 波特五力分析
  • 技術進步
  • 市場未滿足的需求
  • 各國醫療保健支出

第6章：全球市場分析與預測：依中心類型

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按中心類型，2020-2035
    • 醫院輸液中心
    • 醫生輸液中心
    • 獨立輸液中心
  • 市場吸引力分析：按中心類型

第7章：全球市場分析與預測：依治療類型

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依治療類型，2020-2035
    • 抗生素
    • 血液製品
    • 營養產品
    • 免疫抑制劑
    • 免疫促效劑
    • 單株抗體
    • 免疫球蛋白治療
    • 其他
  • 市場吸引力分析：按治療類型

第8章：全球市場分析與預測：按疾病專科

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依疾病專科，2020-2035
    • 腫瘤學
    • 肺部疾病學
    • 神經病學
    • 胃腸道
    • 免疫學
    • 心臟病學
    • 其他
  • 市場吸引力分析：按疾病專科

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2035
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第10章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第12章：亞太市場分析與預測

第13章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2023年）
  • 公司簡介
    • Flexcare Infusion Centers
    • Hawaii Medical Service Association
    • Pure Infusion Suites
    • National Infusion Center Association
    • TwelveStone Health Partners
    • Richmond University Medical Center
    • CitusHealth
    • Valley Health System
    • Cedars-Sinai
    • Arnot Health
    • PharmaScript
    • Naval Medical Center Portsmouth
    • Cheyenne Regional Medical Center
    • Pacific Medical Centers
    • ChristianaCare
Product Code: TMRGL86470

Ambulatory Infusion Centers Market - Scope of Report

TMR's report on the global ambulatory infusion centers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global ambulatory infusion centers market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ambulatory infusion centers market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ambulatory infusion centers market.

Market Snapshot
Market Value in 2024US$ 20.3 Bn
Market Value in 2035US$ 52.3 Bn
CAGR8.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ambulatory infusion centers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ambulatory infusion centers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ambulatory infusion centers market.

The report delves into the competitive landscape of the global ambulatory infusion centers market. Key players operating in the global ambulatory infusion centers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ambulatory infusion centers market profiled in this report.

Key Questions Answered in Global ambulatory infusion centers Market Report:

  • What is the sales/revenue generated by ambulatory infusion centers across all regions during the forecast period?
  • What are the opportunities in the global ambulatory infusion centers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Ambulatory Infusion Centers Market - Research Objectives and Research Approach

The comprehensive report on the global ambulatory infusion centers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ambulatory infusion centers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ambulatory infusion centers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ambulatory Infusion Centers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ambulatory Infusion Centers Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. Regulatory Scenario by Key Countries/Region
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Technological Advancements
  • 5.6. Unmet Needs of the Market
  • 5.7. Healthcare Spending's by Country

6. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Type of Center

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type of Center, 2020-2035
    • 6.3.1. Hospital-based Infusion Centers
    • 6.3.2. Physician-based Infusion Centers
    • 6.3.3. Independent Infusion Centers
  • 6.4. Market Attractiveness Analysis, by Type of Center

7. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Therapy Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 7.3.1. Antibiotics
    • 7.3.2. Blood Products
    • 7.3.3. Nutritional Products
    • 7.3.4. Immunosuppressants
    • 7.3.5. Immunostimulants
    • 7.3.6. Monoclonal Antibodies
    • 7.3.7. Immunoglobulin Therapy
    • 7.3.8. Others
  • 7.4. Market Attractiveness Analysis, by Therapy Type

8. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Disease Specialties

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Specialties, 2020-2035
    • 8.3.1. Oncology
    • 8.3.2. Pulmonology
    • 8.3.3. Neurology
    • 8.3.4. Gastrointestinal
    • 8.3.5. Immunology
    • 8.3.6. Cardiology
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis, by Disease Specialties

9. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Ambulatory Infusion Centers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type of Center, 2020-2035
    • 10.2.1. Hospital-based Infusion Centers
    • 10.2.2. Physician-based Infusion Centers
    • 10.2.3. Independent Infusion Centers
  • 10.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 10.3.1. Antibiotics
    • 10.3.2. Blood Products
    • 10.3.3. Nutritional Products
    • 10.3.4. Immunosuppressants
    • 10.3.5. Immunostimulants
    • 10.3.6. Monoclonal Antibodies
    • 10.3.7. Immunoglobulin Therapy
    • 10.3.8. Others
  • 10.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 10.4.1. Oncology
    • 10.4.2. Pulmonology
    • 10.4.3. Neurology
    • 10.4.4. Gastrointestinal
    • 10.4.5. Immunology
    • 10.4.6. Cardiology
    • 10.4.7. Others
  • 10.5. Market Value Forecast, by Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type of Center
    • 10.6.2. By Therapy Type
    • 10.6.3. By Disease Specialties
    • 10.6.4. By Country

11. Europe Ambulatory Infusion Centers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type of Center, 2020-2035
    • 11.2.1. Hospital-based Infusion Centers
    • 11.2.2. Physician-based Infusion Centers
    • 11.2.3. Independent Infusion Centers
  • 11.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 11.3.1. Antibiotics
    • 11.3.2. Blood Products
    • 11.3.3. Nutritional Products
    • 11.3.4. Immunosuppressants
    • 11.3.5. Immunostimulants
    • 11.3.6. Monoclonal Antibodies
    • 11.3.7. Immunoglobulin Therapy
    • 11.3.8. Others
  • 11.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 11.4.1. Oncology
    • 11.4.2. Pulmonology
    • 11.4.3. Neurology
    • 11.4.4. Gastrointestinal
    • 11.4.5. Immunology
    • 11.4.6. Cardiology
    • 11.4.7. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type of Center
    • 11.6.2. By Therapy Type
    • 11.6.3. By Disease Specialties
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Ambulatory Infusion Centers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type of Center, 2020-2035
    • 12.2.1. Hospital-based Infusion Centers
    • 12.2.2. Physician-based Infusion Centers
    • 12.2.3. Independent Infusion Centers
  • 12.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 12.3.1. Antibiotics
    • 12.3.2. Blood Products
    • 12.3.3. Nutritional Products
    • 12.3.4. Immunosuppressants
    • 12.3.5. Immunostimulants
    • 12.3.6. Monoclonal Antibodies
    • 12.3.7. Immunoglobulin Therapy
    • 12.3.8. Others
  • 12.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 12.4.1. Oncology
    • 12.4.2. Pulmonology
    • 12.4.3. Neurology
    • 12.4.4. Gastrointestinal
    • 12.4.5. Immunology
    • 12.4.6. Cardiology
    • 12.4.7. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type of Center
    • 12.6.2. By Therapy Type
    • 12.6.3. By Disease Specialties
    • 12.6.4. By Country/Sub-region

13. Latin America Ambulatory Infusion Centers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type of Center, 2020-2035
    • 13.2.1. Hospital-based Infusion Centers
    • 13.2.2. Physician-based Infusion Centers
    • 13.2.3. Independent Infusion Centers
  • 13.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 13.3.1. Antibiotics
    • 13.3.2. Blood Products
    • 13.3.3. Nutritional Products
    • 13.3.4. Immunosuppressants
    • 13.3.5. Immunostimulants
    • 13.3.6. Monoclonal Antibodies
    • 13.3.7. Immunoglobulin Therapy
    • 13.3.8. Others
  • 13.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 13.4.1. Oncology
    • 13.4.2. Pulmonology
    • 13.4.3. Neurology
    • 13.4.4. Gastrointestinal
    • 13.4.5. Immunology
    • 13.4.6. Cardiology
    • 13.4.7. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type of Center
    • 13.6.2. By Therapy Type
    • 13.6.3. By Disease Specialties
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Ambulatory Infusion Centers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type of Center, 2020-2035
    • 14.2.1. Hospital-based Infusion Centers
    • 14.2.2. Physician-based Infusion Centers
    • 14.2.3. Independent Infusion Centers
  • 14.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 14.3.1. Antibiotics
    • 14.3.2. Blood Products
    • 14.3.3. Nutritional Products
    • 14.3.4. Immunosuppressants
    • 14.3.5. Immunostimulants
    • 14.3.6. Monoclonal Antibodies
    • 14.3.7. Immunoglobulin Therapy
    • 14.3.8. Others
  • 14.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 14.4.1. Oncology
    • 14.4.2. Pulmonology
    • 14.4.3. Neurology
    • 14.4.4. Gastrointestinal
    • 14.4.5. Immunology
    • 14.4.6. Cardiology
    • 14.4.7. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type of Center
    • 14.6.2. By Therapy Type
    • 14.6.3. By Disease Specialties
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Flexcare Infusion Centers
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Hawaii Medical Service Association
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Pure Infusion Suites
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. National Infusion Center Association
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. TwelveStone Health Partners
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Richmond University Medical Center
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. CitusHealth
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Valley Health System
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Cedars-Sinai
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Arnot Health
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. PharmaScript
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Naval Medical Center Portsmouth
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Cheyenne Regional Medical Center
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pacific Medical Centers
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. ChristianaCare
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 02: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 03: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 04: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 07: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 08: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 09: Europe - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 11: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 12: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 13: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 15: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 16: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 17: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 19: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 20: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 21: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 23: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 24: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035

List of Figures

  • Figure 01: Global Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 02: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 03: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Hospital-based Infusion Centers, 2020-2035
  • Figure 04: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Physician-based Infusion Centers, 2020-2035
  • Figure 05: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Independent Infusion Centers, 2020-2035
  • Figure 06: Global Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 07: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
  • Figure 08: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Antibiotics, 2020-2035
  • Figure 09: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Blood Products, 2020-2035
  • Figure 10: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Nutritional Products, 2020-2035
  • Figure 11: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
  • Figure 12: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunostimulants, 2020-2035
  • Figure 13: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Monoclonal antibodies, 2020-2035
  • Figure 14: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunoglobulin Therapy, 2020-2035
  • Figure 15: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 16: Global Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 17: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 18: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Oncology, 2020-2035
  • Figure 19: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Pulmonology, 2020-2035
  • Figure 20: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Neurology, 2020-2035
  • Figure 21: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Gastrointestinal, 2020-2035
  • Figure 22: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunology, 2020-2035
  • Figure 23: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Cardiology, 2020-2035
  • Figure 24: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 25: Global Ambulatory Infusion Centers Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 26: Global Ambulatory Infusion Centers Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 27: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 28: North America - Ambulatory Infusion Centers Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 29: North America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 30: North America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 31: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 32: North America Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 33: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
  • Figure 34: North America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 35: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 36: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 37: Europe - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Europe - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 39: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 40: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 41: Europe Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 42: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 43: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 44: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 45: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 46: Asia Pacific - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 47: Asia Pacific - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 48: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 49: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 50: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 51: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 52: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 53: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 54: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 55: Latin America - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 56: Latin America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 57: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 58: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 59: Latin America Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 60: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 61: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 62: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 63: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 64: Middle East & Africa - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 65: Middle East & Africa - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 66: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 67: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 68: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 69: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 70: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 71: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035